References
- Mancia G. European Society of Hypertension: A note from the president. J Hypertension 2000;18:1701–1703.
- Cohn JN. Hypertension Therapeutic Research: A Plea for Change in the New Millennium. Am J Hypertension 2002;15:97–98.
- Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, . Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. Blood Pessure 2009;18:308–347.
- Blood Pressure Lowering Treatment Trialists’ Collaboration: Effects of ACE inhibitors, calcium antagonists, and other blood pressure-lowering drugs: results of prospectively designed overviews of randomized trials. Lancet 2000;356:1955–1964.
- Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. BMJ 2003;326:1419–1424.
- The Indian Polycap Study (TIPS). Effects of a polypill (Poly-cap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial. Lancet 2009;373:1341–1351.
- Hedner T, Narkiewicz K, Kjeldsen SE. Hypertension control – A global challenge. Blood Pressure 2005;14:4–5.
- 20th European meeting on hypertension in Oslo June 18–21, 2010. www.esh2010.com.